Spot-on phage therapy: stable formulations, smarter dosing for topical phage application

Area of Science:

• Microbiology
• Biotechnology
• Pharmacology

Background:

• The rise of antimicrobial resistance necessitates novel therapeutic strategies.
• Bacteriophage therapy is gaining traction for topical applications, particularly in wound and burn care.
• Clinical translation of topical phage therapy is hindered by a lack of standardized protocols.

Purpose of the Study:

• To review and synthesize scattered data on topical bacteriophage therapy.
• To identify key factors influencing the efficacy of topical phage treatments.
• To provide a practical guide for developing standardized topical phage therapy regimens.

Main Methods:

• Literature review of published studies on topical phage therapy.
• Analysis of phage titer, multiplicity of infection (MOI), and formulation stability.
• Examination of bacterial load, biofilm maturity, and pharmacokinetic/pharmacodynamic (PK/PD) data.
• Evaluation of wound dressing roles in phage delivery.

Main Results:

• Effective topical phage therapy depends on phage titer (10^7-10^9 PFU/mL), MOI, and formulation stability (hydrogels, creams, sprays).
• Mature biofilms and high bacterial loads require higher, repeated phage doses or combination therapies (e.g., with antibiotics or depolymerases).
• Wound dressings can play a role in controlled phage delivery.

Conclusions:

• Optimizing topical phage therapy requires integrating accurate dosing, intelligent formulation, and strategic application timing.
• Standardized PK/PD frameworks, stability testing, and clinical trials are essential for clinical translation.
• This review serves as a guide for developing efficient and reliable topical phage treatment regimens.